Amgen, Inc. (AMGN) Misses Q1 EPS by 7c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St futures muted as higher oil prices temper risk appetite after S&P record close
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Reddit to join S&P 500 index on Aug. 18, shares leap
- Should you chase this mini rally in gold? Citi weighs in
Amgen (AMGN) Q1 'Disappointing' - Nomura
April 23, 2014 7:43 AM EDTNomura Securities analyst M. Ian Somaiya reiterated a Neutral rating on Amgen (NASDAQ: AMGN) and trimmed his price target from $130 to $129 following 'Disappointing' Q1 results.
Somaiya said, "We are lowering estimates and target price to $129 from $130 following a disappointing 1Q14 earnings that... More
